United States (US) Carcinoembryonic Antigen Market (2025-2031) | Size & Revenue, Industry, Competitive Landscape, Segmentation, Analysis, Share, Outlook, Growth, Forecast, Trends, Companies, Value

Market Forecast By Application (Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Breast Cancer, Thyroid Cancer, Others) And Competitive Landscape
Product Code: ETC9961784 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sumit Sagar No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Carcinoembryonic Antigen Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, the United States saw a significant decline in carcinoembryonic antigen import shipments, with a negative CAGR of -31.87% from 2020 to 2024. The top exporting countries to the USA were Austria, Metropolitan France, Italy, Germany, and Brazil. Despite the low concentration indicated by the Herfindahl-Hirschman Index (HHI), the growth rate plummeted by -39.06% from 2023 to 2024. This data suggests a challenging market environment for carcinoembryonic antigen imports into the United States in 2024.

United States (US) Carcinoembryonic Antigen Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • United States (US) Carcinoembryonic Antigen Market Outlook
  • Market Size of United States (US) Carcinoembryonic Antigen Market, 2024
  • Forecast of United States (US) Carcinoembryonic Antigen Market, 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Revenues & Volume for the Period 2021- 2031
  • United States (US) Carcinoembryonic Antigen Market Trend Evolution
  • United States (US) Carcinoembryonic Antigen Market Drivers and Challenges
  • United States (US) Carcinoembryonic Antigen Price Trends
  • United States (US) Carcinoembryonic Antigen Porter's Five Forces
  • United States (US) Carcinoembryonic Antigen Industry Life Cycle
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Pancreatic Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Ovarian Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Thyroid Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Carcinoembryonic Antigen Market Revenues & Volume By Others for the Period 2021- 2031
  • United States (US) Carcinoembryonic Antigen Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • United States (US) Carcinoembryonic Antigen Top Companies Market Share
  • United States (US) Carcinoembryonic Antigen Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Carcinoembryonic Antigen Company Profiles
  • United States (US) Carcinoembryonic Antigen Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Carcinoembryonic Antigen Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Carcinoembryonic Antigen Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Carcinoembryonic Antigen Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Carcinoembryonic Antigen Market - Industry Life Cycle

3.4 United States (US) Carcinoembryonic Antigen Market - Porter's Five Forces

3.5 United States (US) Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F

4 United States (US) Carcinoembryonic Antigen Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the US population

4.2.2 Rising demand for early cancer detection and diagnosis

4.2.3 Technological advancements in CEA testing methods

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for CEA testing

4.3.2 High cost associated with CEA testing procedures

4.3.3 Limited awareness about CEA testing among the general population

5 United States (US) Carcinoembryonic Antigen Market Trends

6 United States (US) Carcinoembryonic Antigen Market, By Types

6.1 United States (US) Carcinoembryonic Antigen Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.1.4 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F

6.1.6 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F

6.1.8 United States (US) Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Carcinoembryonic Antigen Market Import-Export Trade Statistics

7.1 United States (US) Carcinoembryonic Antigen Market Export to Major Countries

7.2 United States (US) Carcinoembryonic Antigen Market Imports from Major Countries

8 United States (US) Carcinoembryonic Antigen Market Key Performance Indicators

8.1 Adoption rate of CEA testing among healthcare providers

8.2 Number of research studies and clinical trials focusing on CEA testing

8.3 Patient engagement and participation in CEA screening programs

9 United States (US) Carcinoembryonic Antigen Market - Opportunity Assessment

9.1 United States (US) Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F

10 United States (US) Carcinoembryonic Antigen Market - Competitive Landscape

10.1 United States (US) Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024

10.2 United States (US) Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All